Literature DB >> 9821089

Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population.

D Us1, G Hasçelik.   

Abstract

OBJECTIVES: Helicobacter pylori infection is recognized as being strongly associated with chronic gastritis, duodenal ulceration and probably gastric carcinoma. Seroepidemiological studies have shown that a large proportion of healthy people have antibodies against H. pylori. A serological study was conducted in an asymptomatic Turkish population to investigate the seropositivity rate of H. pylori and to detect the relationship with age. SUBJECTS AND METHODS: A total of 657 serum samples collected from 331 male and 326 female people in different age groups who had no gastrointestinal complaints were studied by a commercial ELISA test for the presence of H. pylori-IgG antibodies.
RESULTS: Three hundred and forty-eight subjects (53%) were seropositive. The overall seropositivity rates did not differ with sex. Antibody prevalence increased progressively with age. The seropositivity rates were as follows: 17.4% < 1 year old; 15.5% aged 1-4; 30.6% aged 5-9; 47.3% aged 10-14; 58.4% aged 15-19; 62.6% aged 20-29; 67.6% aged 30-39; 81.3% aged 40-49; and 66.3% over 50 years of age.
CONCLUSIONS: This study indicated that more than 30% of the subjects acquired infection before teenage and that about 70% of adults had antibodies against H. pylori in our population. The high prevalence and early acquisition of H. pylori infection may be related in part to socioeconomic status and traditional living conditions in Turkey.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821089     DOI: 10.1016/s0163-4453(98)80169-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

1.  Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia.

Authors:  Yusuf Erzin; Vedat Koksal; Sibel Altun; Ahmet Dobrucali; Mustafa Aslan; Sibel Erdamar; Süha Goksel; Ahmet Dirican; Bekir Kocazeybek
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

2.  Helicobacter pylori seropositivity in fibromyalgia syndrome.

Authors:  Nuray Akkaya; Semih Akkaya; Yusuf Polat; Meral Turk; Tufan Turk; Elif Turhal; Fusun Sahin
Journal:  Clin Rheumatol       Date:  2010-12-01       Impact factor: 2.980

Review 3.  Helicobacter pylori eradication in West Asia: a review.

Authors:  Hafez Fakheri; Zohreh Bari; Mohsen Aarabi; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.

Authors:  Yusuf Erzin; Sibel Altun; Ahmet Dobrucali; Mustafa Aslan; Sibel Erdamar; Ahmet Dirican; Murat Tuncer; Bekir Kocazeybek
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

5.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 6.  Helicobacter pylori Infection in the general population: A Middle Eastern perspective.

Authors:  Hossein Khedmat; Reza Karbasi-Afshar; Shahram Agah; Saeed Taheri
Journal:  Caspian J Intern Med       Date:  2013

7.  Influence of H pylori on plasma ghrelin in patients without atrophic gastritis.

Authors:  Mehmet Cindoruk; Ilhan Yetkin; Serpil Muge Deger; Tarkan Karakan; Erdal Kan; Selahattin Unal
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study.

Authors:  Farzad Izadi; Aslan Ahmadi; Shadi Ghourchian; Ahmad Daneshi; Faramarz Memari; Ehsan Khadivi; Shabahang Mohammadi
Journal:  Infect Agent Cancer       Date:  2012-04-19       Impact factor: 2.965

9.  Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey.

Authors:  Huseyin Alkim; Mustafa Iscan; Feriha Oz
Journal:  Libyan J Med       Date:  2011-09-08       Impact factor: 1.657

10.  Prevalence of Helicobacter pylori in children and their family members in a district in Turkey.

Authors:  Abdullah Ceylan; Ercan Kirimi; Oğuz Tuncer; Kürşat Türkdoğan; Sevil Ariyuca; Nesrin Ceylan
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.